These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Long-term sublingual immunotherapy provides better effects for patients with Japanese cedar pollinosis. Hamada S, Kobayashi Y, Sakamoto D, Shimamura A, Kuroda K, Kawachi R, Kanda A, Asako M, Gotoh M, Okubo K, Tomoda K, Iwai H. Auris Nasus Larynx; 2021 Aug; 48(4):646-652. PubMed ID: 33526319 [Abstract] [Full Text] [Related]
8. Decreased numbers of metachromatic cells in nasal swabs in Japanese cedar pollinosis following sublingual immunotherapy. Otsuka K, Otsuka H, Matsune S, Okubo K. Immun Inflamm Dis; 2020 Sep; 8(3):333-341. PubMed ID: 32468704 [Abstract] [Full Text] [Related]
9. Long-term treatment of Japanese cedar pollinosis with Japanese cedar pollen SLIT drops and persistence of treatment effect: A post-marketing clinical trial. Nomura Y, Okubo K, Nakamura T, Sawaki S, Kitagou H, Idei N, Kaneko S, Kobayashi S, Tanaka Y, Okamoto Y. Allergol Int; 2021 Jan; 70(1):96-104. PubMed ID: 32653209 [Abstract] [Full Text] [Related]
11. [CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY IN THE THIRD TREATED YEAR WITH JAPANESE CEDAR POLLINOSIS IN 2017]. Yuta A, Ogawa Y, Suzuki Y, Ogihara H, Ohta N, Kozaki H, Shimizu T. Arerugi; 2017 Jan; 66(9):1172-1180. PubMed ID: 29129888 [Abstract] [Full Text] [Related]
14. [Antigen specific sublingual immunotherapy for pediatric Japanese cedar pollinosis]. Yuta A, Miyamoto Y, Ogihara H, Hattori R, Okubo K. Arerugi; 2009 Feb; 58(2):124-32. PubMed ID: 19329875 [Abstract] [Full Text] [Related]
16. Treatment duration-dependent efficacy of Japanese cedar pollen sublingual immunotherapy: Evaluation of a phase II/III trial over three pollen dispersal seasons. Yonekura S, Gotoh M, Kaneko S, Kanazawa K, Takeuji Y, Okubo K, Okamoto Y. Allergol Int; 2019 Oct; 68(4):494-505. PubMed ID: 31257168 [Abstract] [Full Text] [Related]
17. Long-Term Efficacy and Dose-Finding Trial of Japanese Cedar Pollen Sublingual Immunotherapy Tablet. Gotoh M, Yonekura S, Imai T, Kaneko S, Horikawa E, Konno A, Okamoto Y, Okubo K. J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1287-1297.e8. PubMed ID: 30537561 [Abstract] [Full Text] [Related]
18. Immunological effects of sublingual immunotherapy with Japanese cedar pollen extract in patients with combined Japanese cedar and Japanese cypress pollinosis. Kikuoka H, Kouzaki H, Matsumoto K, Arai H, Yamamoto S, Tojima I, Shimizu S, Miyashita H, Ogawa Y, Osada T, Okano M, Yuta A, Shimizu T. Clin Immunol; 2020 Jan; 210():108310. PubMed ID: 31743749 [Abstract] [Full Text] [Related]
19. [Adherence and Clinical Outcome of Sublingual Immunotherapy for Japanese Cedar Pollinosis]. Yuta A, Ogawa Y, Suzuki Y, Arikata M, Kozaki H, Shimizu T, Ohta N. Nihon Jibiinkoka Gakkai Kaiho; 2016 Dec; 119(12):1504-10. PubMed ID: 30035481 [Abstract] [Full Text] [Related]
20. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis. Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Yamamoto H, Kunii N, Sakurai D, Fujimura T, Nakazawa K, Yasueda H. Int Arch Allergy Immunol; 2008 Dec; 146(1):76-84. PubMed ID: 18087165 [Abstract] [Full Text] [Related] Page: [Next] [New Search]